Megan E. McNutt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Megan E. McNutt has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Cankun Wang
Department of Biomedical Informatics, College of Medicine, Ohio State University, Columbus, USA
25 shared publications - Qin Ma
The Ohio State University
25 shared publications - Anjun Ma
Ohio State University
24 shared publications - Afaf E.G. Osman
17Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, Utah
23 shared publications - Ahmad A. Tarhini
Departments of Cutaneous Oncology and Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
23 shared publications - Aik Choon Tan
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
23 shared publications
Latest Publications
- Open Access
- 10 April 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 173 (2) , 487-496
Tracheostomy Outcomes in Children With Bronchopulmonary Dysplasia
Objective: To quantify the tracheostomy‐related morbidity and mortality, readmissions, and airway interventions in tracheostomy‐dependent children with bronchopulmonary dysplasia (BPD).Study Design: Retrospective chart review.Setting: Tertiary care children's hospital.Methods: Infants with BPD who received tracheostomy by an otolaryngologist between January 2016 and December 2022 at a single institution were included. Surviving patients were followed to at least 2 years of age. Data were extracted from electronic medical records for patient characteristics, clinical encounters, and surgical visits.Results: There were 76 patients included in this study. The overall mortality was 30.3% (23/76) with one tracheostomy‐related death. Tracheostomy occurred at a median 56 weeks postmenstrual age (PMA). Tracheitis was the most common short‐ and long‐term adverse event (within the first postoperative week, 21%; after postoperative day 7, 81%). Other complications observed include stomal granuloma (77%), airway stenosis (69%), and accidental decannulation (38%). The 30‐day and 2‐year readmission rates were 32% and 61%, of which 61% and 76% were for tracheostomy‐related causes, respectively. The most common reason for readmission over these time periods was tracheitis. Overall decannulation rate for surviving patients was 68%, and decannulation occurred at a median 3.1 years of age. Most surviving patients returned for operative airway intervention (85%); 43% required open airway reconstruction.Conclusion: Tracheostomy‐related morbidity was low in this cohort despite a majority of patients experiencing multiple tracheostomy‐related adverse events and readmissions. Patient comorbid conditions, BPD severity, and socioeconomic status were not significantly associated with outcomes. Larger studies are needed to assess the airway interventions and outcomes in this population.
- 10 April 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 173 (2) , 487-496
Open AccessTracheostomy Outcomes in Children With Bronchopulmonary Dysplasia
Objective: To quantify the tracheostomy‐related morbidity and mortality, readmissions, and airway interventions in tracheostomy‐dependent children with bronchopulmonary dysplasia (BPD).Study Design: Retrospective chart review.Setting: Tertiary care children's hospital.Methods: Infants with BPD who received tracheostomy by an otolaryngologist between January 2016 and December 2022 at a single institution were included. Surviving patients were followed to at least 2 years of age. Data were extracted from electronic medical records for patient characteristics, clinical encounters, and surgical visits.Results: There were 76 patients included in this study. The overall mortality was 30.3% (23/76) with one tracheostomy‐related death. Tracheostomy occurred at a median 56 weeks postmenstrual age (PMA). Tracheitis was the most common short‐ and long‐term adverse event (within the first postoperative week, 21%; after postoperative day 7, 81%). Other complications observed include stomal granuloma (77%), airway stenosis (69%), and accidental decannulation (38%). The 30‐day and 2‐year readmission rates were 32% and 61%, of which 61% and 76% were for tracheostomy‐related causes, respectively. The most common reason for readmission over these time periods was tracheitis. Overall decannulation rate for surviving patients was 68%, and decannulation occurred at a median 3.1 years of age. Most surviving patients returned for operative airway intervention (85%); 43% required open airway reconstruction.Conclusion: Tracheostomy‐related morbidity was low in this cohort despite a majority of patients experiencing multiple tracheostomy‐related adverse events and readmissions. Patient comorbid conditions, BPD severity, and socioeconomic status were not significantly associated with outcomes. Larger studies are needed to assess the airway interventions and outcomes in this population.
- Open Access
- 25 October 2024
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 135 (10) , 1021-1024
Cell-Free RNA Signatures in Maternal Blood with Fetal Congenital Heart Disease
- 25 October 2024
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 135 (10) , 1021-1024
Open AccessCell-Free RNA Signatures in Maternal Blood with Fetal Congenital Heart Disease
- Open Access
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Upset plot of overall identified species in 12 cancer types.
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Upset plot of overall identified species in 12 cancer types.
- Open Access
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
FIGURE 3 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Network visualization of identified microbial communities in COAD and THCA. The cancer-type nodes were highlighted by an octagon shape, while the microbial species nodes were highlighted in a circle shape. The thickness of the edges in the network reflects the attention weight scores, indicating the strength of the relationship between the species and cancer. In addition, the metabolic compound nodes were highlighted with a yellow triangle shape, while the phylogenetic relationship edges were highlighted in gray. A, COAD-associated microbes highlighted with metabolic compound. B, THCA-associated microbes highlighted with metabolic compound. C, COAD-associated microbes highlighted with phylogenetic relationships. D, THCA-associated microbes highlighted with phylogenetic relationships.
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 3 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Network visualization of identified microbial communities in COAD and THCA. The cancer-type nodes were highlighted by an octagon shape, while the microbial species nodes were highlighted in a circle shape. The thickness of the edges in the network reflects the attention weight scores, indicating the strength of the relationship between the species and cancer. In addition, the metabolic compound nodes were highlighted with a yellow triangle shape, while the phylogenetic relationship edges were highlighted in gray. A, COAD-associated microbes highlighted with metabolic compound. B, THCA-associated microbes highlighted with metabolic compound. C, COAD-associated microbes highlighted with phylogenetic relationships. D, THCA-associated microbes highlighted with phylogenetic relationships.
- Open Access
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Metabolic compounds relationships microbial signatures.
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Metabolic compounds relationships microbial signatures.
- Open Access
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
FIGURE 1 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Overview of the MEGA workflow. Four main steps were included in carrying out model training and biological gene network inference. MEGA uses ORIEN datasets and two database dependencies as the data sources. Preprocessing steps are employed to generate AI-ready data for graph neural network training. After deep learning model training, the cancer-associated microbial signatures were selected on the basis of the attention scores of each species at the sample level. The final results of the identified cancer-associated microbial communities have been provided in a tabular format and are available for additional visualization.
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 1 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Overview of the MEGA workflow. Four main steps were included in carrying out model training and biological gene network inference. MEGA uses ORIEN datasets and two database dependencies as the data sources. Preprocessing steps are employed to generate AI-ready data for graph neural network training. After deep learning model training, the cancer-associated microbial signatures were selected on the basis of the attention scores of each species at the sample level. The final results of the identified cancer-associated microbial communities have been provided in a tabular format and are available for additional visualization.
- Open Access
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 7 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Phylogenetic relationships of microbial signatures.
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 7 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Phylogenetic relationships of microbial signatures.
- Open Access
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Identified cancer-associated microbial signatures in all studied cancer types.
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Identified cancer-associated microbial signatures in all studied cancer types.
- Open Access
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Shared and unique microbial species identified across different cancer types.
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Shared and unique microbial species identified across different cancer types.
- Open Access
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Metabolomics data from colorectal cancer samples.
- 5 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
Metabolomics data from colorectal cancer samples.